Sunday, November 23, 2014

Heamatococcus pluvialis for Health care

Heamatococcus pluvialis freshwater specie is a chlorophyta from the family heamatococaceae. This specie is very famous because it is rich in the powerful antioxidant asthaxanthin, which has several importance and usefulness in aquaculture, cosmetics, and pharmaceuticals. The higher concentration of asthaxanthin can be found in the resting cells which are produced and rapidly accumulated when the environmental conditions become unfavorable for normal cell growth. Bright light, low salinity and low nutrients are some of these unfavorable conditions.
Heamatococcus pluvialis is usually found in temperate regions around the world. Their resting cysts are the causes of the blood red color seen in the bottom of dried rock pools and bird baths. This color is caused by asthaxanthin which has been found according to researches to protect the collagen found in the cells from the detrimental effects of direct exposure to UV- radiation. Asthaxanthin is known to contain protective properties that protect your cells from damages. It is important that you get nutrition that contains a good amount of asthaxanthin. Heamatococcus pluvialis delivers a very rich content of asthaxanthin that ensures the protection of your cells and the collagen contained in them which is very relevant in the protection of your youthful beauty and appearance.
Apart from Heamatococcus pluvialis, asthaxanthin can also be found in yeast, shrimp, salmon, etc. The major and primary source of asthaxanthin remains the microalgae heamatococcus pluvialis. When your nutrition includes asthaxanthin-rich supplements, you are sure of getting protection of collagen and skin cells from being damaged by UV-radiations. Heamatococcus pluvialis apart from protecting your collagen from damages equally contains antioxidant activities and prevents cardiovascular diseases and the immune system. In this way, a diet rich in the asthaxanthin-rich heamatococcus pluvialis protects and enhances your beauty through health protection. So those microalgae are not one of those microorganisms without any kind health and beauty benefits.

Friday, November 21, 2014

The Pipal Tree - Ravi Chettu

Botanical Name : Ficus religiosa L.Synonyms : Urostigma religiosum L.
Family : Moraceae

Local Name : Odia : Pipal, Aswatta,Jori,Osta, Hindi : Pipal, English: Peepal,
Telugu : Ravi,,Ashvathamu,Bodhi,Pippali, Tamil : Asogam , Kannada : Pipar
Bengali : Asvatha, Ashathwa

Habitat : Common, wild or cultivated, often epiphytic on trees and dilapidated walls.

Distribution: India; Sub-Himalayan forest, Myanmar, Sri Lanka, Malaysia, Cochinchina, Yunnan (China), N.Thailand

Flowering & Fruiting time : June-October

Conservation Status : Not yet evaluated 

Habit : Large Tree up to 30 metres, epiphytic when  young.
Leaf : Leaves more or less pendulous, broadly ovate,  margin often repand, very long caudate, coriaceous, dark  green and shining above, base coardate or truncate with 3 strong principal nerves and 2-4 weaker ones, looped  within the margin, acumen many nerved; petiole 
slender; stipules linear subulate.Figs : Figs axillary, geminate, sessile, depressed-globose, 
smooth, glabrous, dark purple when ripe.


Uses :
Ficus religiosa has been traditionally used in Indian system medicine for treatment of asthma, diabetes, diarrhea, epilepsy, gastric problems, inflammatory disorders etc.All parts of the tree used in medicine. 
Leaf : Its leaves serve as a wonderful laxative as well as  tonic for the body. It is specially useful for patients suffering  from jaundice and heart disorders. It helps to control the palpitation of heart and there by combat the cardiac  weakness.
Bark: The bark is astringent, sweet, cooling and aphrodisiac.  It is used in the treatment of gonorrhoea, diarrhoea, dysentery, haemorrhoids and gastric ulcer. The paste of powdered bark is good absorbent for inflammatory swelling and useful in burns.
Figs : Figs are laxative and digestive. The dried fruits are pulverised and administrated with water to cure asthma.

Mythological importance :
The Peepal ( Ficus religiosa ) plant has the great importance in India especially among the Budhhist. Lord Goutama Buddha attained enlightenment while meditating underneath a Peepal tree. The site is at present Bodh Gaya in Bihar, India. A branch of this tree was rooted in Anuradhapura, Sri Lanka in 288 BC and is known as Jaya Sri Maha Bodhi, it is the oldest living human planted flowering plant in the world with a definitive planted date. 
Hindus in India spiritually regarded Peepal tree as the holy tree and the people  use its leaves for the religious purposes. It is widely planted in temple premises. Women worship this tree as a symbol of 
fertility.

Source
 Saxsena, H.O. & Brahmam, M. (1994). The Flora of Orissa, Vol. III, pp:1719 - 1720. 
 Sharma P.C.; Yelne M.B.; Dennis T.J. (2005 ). Database on Medicinal Plants Used in Ayurveda, 
Vol.3, pp: 130-139.
 www.en.wikipedia.org/wiki/ficus_religiosa




Saturday, November 15, 2014

Saraca asoca - SITA ASOKA

Botanical Name : Saraca asoca (Roxb.) De Wilde
Family : Caesalpiniaceae
Synonyms : Saraca indica L., Jonesia asoca Roxb.
Local Name :  Odia : Ashoka English: Ashok Hindi : Ashok Telugu : Kankeli, Asokamu, Vanjulamu
Tamil : Asogam Kannada : Husangid-ba, Usangid-ba
Habitat It is grown all over India. It occur up tothe altitude 600 meters. It is also cultivated in many gardens because of it’s decorative orange red flowers.
Distribution India, Central and E. Himalayan, W. Peninsula, Bangladesh, Myanmar, Sri Lanka, Malaysia.
Flowering time : March-April
Fruiting time : September
Conservation Status Critically endangered

Description : Ashoka is one of the most legendary and sacred trees of India
Habit : Trees or large shrub.
Leaf : Leaves abruptly pinnate, with few pairs of leaflets.
Inflorescence : Corymbose panicles axillary or terminal. .
Flowers : yellowish to deep red, with short pedicels. Calyx tubular, lobes 4.Petals absent. Stamens usually 7, filaments long, filiform, anthers versatile, dehiscing longitudinally. Ovary compressed, oblong, ovules few to more than 10; style filiform; stigma terminal, capitate.
Fruit : Legume compressed, oblong, slightly curved and oblique, leathery to rather woody.
Seed : Seeds 1–8, compressed, obovate-orbicular, ex-albuminous.

Mythological importance : The Ashoka ( Saraca asoca ) plant is one of the sacred and legendary trees of India. Buddhists, Hindus and Jains revere the tree. It is usually associated with Kamadeva, the Hindu God of love. In the Indian epic “Ramayana” there is mention of Ashoka Vatika where Hanuman had met Mata Sita and the Ashoka Vatika is nothing but the garden of Ashoka trees.
In Odisha state , on car festival of Lord Lingaraj in the month of Chaitra, the day called as
Ashokastami on which the Ashok flowers are used in the worship of Lord Lingaraj.

Saraca asoca Source
 Saxsena, H.O. & Brahmam, M. (1994). The Flora of Orissa, Vol. I, pp: 401 - 402.
 Swain B.K. & Dash,S.K. (2007 ) Visual guide to Wild Medicinal Plants of Orissa, pp: 42-43.
 www.en.wikipedia.org/wiki/
Saraca_asoca
 www.envis.frlht.org

Tuesday, November 11, 2014

Living Roots Bridge

Living Roots Bridge - Cherrapunji, Meghalaya

In Cherrapunji, Meghalaya, man has befriended nature and cajoled it into bending to his ways. People build bridges, but the Khasis of Meghalaya, they grow bridges. Ficus Elastica or the Rubber Tree produces strong secondary roots from their trunks. These have been trained to grow
in a particular direction using betel-nut trunks, forming sturdy, living bridges over decades. Some of these bridges are more than a hundred feet long. The Umshiang Double Decker Bridge is truly one of a kind in the entire world. Some ancient root bridges are over 500 years old.

 



Meghalaya's Living root bridges
This is the only root brides found in the world. Its located in the southern part of Meghalaya, India.
Please see the link : http://www.nidokidos.org/threads/230993

Ebola : A Viral disease - threat to human life

Ebola: At a glance

Ebola electron microscopeWhat is Ebola?

Ebola disease is a life-threatening illness caused by the Ebola virus. In December 2013, a 2-year-old toddler died in a rural village in Guinea, sparking the largest Ebola outbreak the world has ever known (Baize et al., 2014). The outbreak primarily involves three countries in Western Africa: Guinea, Liberia, and Sierra Leone (although there have been additional cases/deaths in other countries). As of early November 2014, there have been over 13,000 cases and almost 5,000 deaths, although experts believe that these numbers could be 250% greater as many patients never seek medical assistance. This outbreak is larger than all previous Ebola outbreaks combined, and the Center for Disease Control (CDC) predicts the disease could spread to other West African countries, infecting over 1 million people by January 2015 (Meltzer et al., 2014)!
Ebola map of disease spread
The Ebola outbreak is serious because:
  • Previous outbreaks were generally limited to rural villages, but the 2014 outbreak has moved into more densely-populated areas where there is increased opportunity for human-to-human transmission. 
  • There is currently no vaccine or specific medication for Ebola, and the threat of the disease spreading can cause widespread panic around the world.

How does virus replication work?

Many viruses follow the same sequence of events to replicate themselves. In regards to the Ebola virus:
  1. The Ebola virus slips inside of a human immune cell (e.g. macrophage).
  2. The virus turns the cell into a virus factory, assembling a clone army of the Ebola virus. Meanwhile, chemicals that impair the blood’s ability to clot (a condition called thrombocytopenia) are released into the bloodstream. This is what causes the unexplained bleeding in patients.
  3. The cell eventually explodes releasing Ebola viruses that infect nearby healthy cells. The exploding cell sends out chemical signals which seep into the bloodstream and alert the immune  system about the infection. The immune system’s response to the invading virus is what causes the patient’s flu-like symptoms (e.g. fever).
Ebola pathophysiology with virus replication

What are the symptoms of Ebola and how is it diagnosed?

It takes between 2 to 21 days (most commonly: 8-10 days) for the Ebola virus to replicate enough to cause symptoms, and initially Ebola can look like a case of a bad flu. To help make things clear, the CDC has listed two key criteria that a patient must meet to raise suspicion of Ebola:
Ebola clinical diagnostic criteria
Ebola can cause many other symptoms including weakness, poor appetite, rash, red eyes, hiccups, cough, chest pain, and difficulty breathing/swallowing. On their own, these symptoms do not indicate that a person has Ebola, since they could be caused by a number of things.
If health care professionals suspect Ebola, they’ll order the following blood tests to confirm the diagnosis:
  • Polymerase Chain Reaction (PCR): Looks for viral RNA
  • Enzyme-Linked ImmunoSorbent Assay (ELISA): Looks for anti-viral antibodies

How does Ebola spread?

Ebola is spread when the bodily fluids of a sick patient get inside of a healthy person. These bodily fluids include blood, vomit, feces, urine, saliva, sweat, breast milk, and semen. The virus can survive in bodily fluids that come in contact with surfaces like floors, walls, and handrails for about 24 hours although the chance of infection after a few hours drops significantly (Center for Disease Control, 2014c). Family, friends, and healthcare professionals all care for patients and are at higher risk of coming into contact with the virus. These folks and anyone else at risk (e.g. funeral directors and lab workers) should protect themselves with personal protective equipment, and remove it in the correct order: gloves, then face shield, then gown, and finally mask!
Graph of total cases and death for Ebola
Ebola can also spread through contact with body fluids of infected bats and primates, placing individuals who work with or in close proximity to these animals at a higher risk of contracting the disease.
Once a patient recovers and is symptom-free, he or she is no longer able to transmit the virus. The one exception is transmission through semen, which can transmit Ebola for up to 3 months after infection. Ebola patients are encouraged to abstain from sex during this time. Ebola survivors can go on to have a normal life and are immune to the virus for up to 10 years.
To be clear, Ebola does not spread through the air, through water, or through food, so you can breathe, drink, and eat without worry!

How likely are you to get Ebola?

It’s really useful to know how many people are likely to get infected from a single contagious patient (assuming that nobody gets vaccinated). A number called R₀ (pronounced: R-“not”) allows scientists to rank how contagious a disease is:
  • R₀ of 0 means that nobody will catch the infection
  • R₀ of 1 means that 1 new person will catch the infection
  • R₀ of 5 means that 5 new people will catch the infection, and so on...
In some diseases, a single patient can spread the disease for days (e.g. Ebola) and in others, for decades (e.g. HIV). It turns out that Ebola has an R₀ of 2, which means that a single patient will transmit the virus to an average of 2 other people (unless we intervene). Compare this with one of the most contagious viruses around - Measles, which can travel in the air and spread to an average of 18 people!
R-nought for various diseases including Ebola
Sources: Center for Disease Control & World Health Organization, n.d.; Meltzer et al., 2014; Mills, Robins, & Lipsitch, 2014

How can you treat Ebola?

Unfortunately there is no direct treatment for Ebola (no vaccines or medications) yet. Instead, health care workers provide supportive care, which focuses on keeping the patient alive during the illness while his/her body fights the disease. Supportive care includes:
  • Keeping the patient well hydrated with intravenous fluids
  • Maintaining the patient’s blood pressure
  • Helping the patient breathe, if needed
  • Treating other infections or ailments that come up
Typically people who are likely to survive begin to recover between 6 and 11 days after symptoms initially began. Older patients and those that have more serious symptoms such as bleeding early on in the course of the disease typically die within 6 to 16 days after symptoms initially began (Center for Disease Control, 2014b).

Consider the following:

Why are some countries more affected by Ebola than others? The answer comes down to having an effective public health system. There is a race taking place. On one side, the virus is quickly moving from one person to another. On the other side, the public health team is trying to find and isolate everyone with Ebola so that the virus can’t spread. Speed matters on both sides, and if the public health team can move quicker than the virus, then transmission ends. This requires good surveillance and contact tracing.
  • Surveillance: Some countries have excellent public health systems, and healthcare providers at clinics/hospitals call public health departments about any patient who has an unusual illness or death. Other countries have many rural populations that cannot visit major health facilities because they’re too far away. In these cases community health workers are often sent out, but they sometimes can’t get to every community. As a result, people may get sick and die without the public health team ever learning about it, and the disease can spread far and wide without anyone noticing.
  • Contact tracing: Once a patient is diagnosed with Ebola, the patient is isolated to prevent further chance of spreading the disease. Public health teams then make a list of everyone the patient may have spread the disease to while the patient had symptoms and monitors them for symptoms for 21 days. If one of those people gets sick, the public health team will isolate them and make another list of everyone this new patient may have spread the disease to while this new patient had symptoms. Ideally there should be no one on the list if the public health team works fast enough!
For more information, check out our video on the Ebola outbreak!

References
Baize, S., Pannetier, D., Oestereich, L., Rieger, T., Koivogui, L., Magassouba, N., … Günther, S. (2014). Emergence of Zaire Ebola Virus Disease in Guinea. New England Journal of Medicine, 371(15), 1418–1425. doi:10.1056/NEJMoa1404505
Center for Disease Control. (2014a). Ebola (ebola virus disease)
Center for Disease Control. (2014b). Ebola virus disease information for clinicians in u.s. healthcare settings
Center for Disease Control. (2014c). Interim Guidance for Environmental Infection Control in Hospitals for Ebola Virus
Center for Diease Control & World Health Organization. (n.d.). History and epidemiology of global smallpox eradication. Smallpox: Disease, Prevention, and Intervention. 16-17.
Meltzer, M., Atkins, C., Santibanez, S., Knust, B., Petersen, B., Ervin, E., … Washington, M. (2014). Estimating the future number of cases in the ebola epidemic - Liberia and serra leon Centers for Disease Control and Prevention. 63(03);1-14.
Mills, C. E., Robins, J. M., & Lipsitch, M. (2004). Transmissibility of 1918 pandemic influenza. Nature, 432(7019), 904–906. doi:10.1038/nature03063

Tuesday, October 28, 2014

Albert Sabin, who developed oral Polio vaccine

Please see the following link : http://en.wikipedia.org/wiki/Albert_Sabin, for profile of Dr.Albert Sabin, who developed oral Polio vaccine.

Salk - Father of Biophilosophy

How Much Money Did Jonas Salk Potentially Forfeit By Not Patenting The Polio Vaccine?
Salk was not called the “Father of Biophilosophy” without reason. I have explained the possible reasons why he did not patent the vaccine here: Why didn’t Jonas Salk patent the polio vaccine?
For those who want a short answer, Salk would have been richer by $7 billion if his vaccine were patented. Continue reading for how the number was arrived at.
First a little bit of history and vaccine mechanism:
·         Producing vaccine on a large scale requires virus samples in huge quantities and the tech did not exist when Salk started working on his vaccine.
·         Folks from Harvard – Enders and Weller – should be given credit for coming up with an effective way to grow the virus on tissue scraps without getting contaminated by bacteria (they won the 1954 Nobel prize for their efforts), and this technique was used in the production of the Salk vaccine.
·         Albert Sabin came up with a vaccine shortly after Salk, which he claimed was more effective (debatable). However the important thing is he did not patent his vaccine either, and both their discoveries were donated for the benefit of mankind.
·         Salk developed a intravenous “killed virus” vaccine, Sabin developed an oral “live weakened” one. The principle is – live vaccine builds immunity for a longer time span, where as killed vaccine needs a “booster” dose to develop life long immunity.
·         The Sabin vaccine works by counteracting transmission through the intestinal cavity (where the infection begins), making it a better choice for eradication.
·         Salk vaccine receivers can still transmit the virus, whereas the Sabin ones do not.
To tackle the question of how much money he forfeited by not patenting his vaccine, the following facts are to be considered:
·         The oral polio vaccine is the type widely used all over the world today, as it is cheaper. People might quote a lot of other reasons, but money is the primary reason (It costs $2.2 extra per child to administer the intravenous vaccine). The secondary reason is children in under developed countries (where the vaccine is administered for free under humanitarian missions) may not visit the doctor a second time, and vaccination has to be done in a single visit. Efficiency gains importance over many other criteria in these cases.
·         Center for Disease Control, Atlanta recommended that Salk virus be used in 1990, and kids in United States are immunized using the safer “killed” intravenous vaccine instead of the “live” vaccine, as chances of a healthy child getting infected exist.
·         The cost of the vaccine would have gone up by 25% if the patent licensing costs are included.
·         Distribution of the money spent on medicines by income groups: 90% of all medicines produced in the world are consumed by the upper 15% of the income group. Better said using charts Poor:1%, Middle 8%, Rich: 90% :